Completed PHASE3 INTERVENTIONAL 2-arm NCT01392768

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

A Double-blind, Phase III, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levetiracetam as Adjunctive Therapy, in Partial Seizures Control Associated With Refractory Focal Epilepsy

Sponsor: Ache Laboratorios Farmaceuticos S.A.

Conditions Epilepsy Partial Seizures

Interventions Levetiracetam Placebo

Updated 5 times since 2017 Last updated: Oct 27, 2016 Started: Jan 31, 2013 Primary completion: Jul 31, 2015 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Epilepsy and Partial Seizures and is currently completed. Ache Laboratorios Farmaceuticos S.A. leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ache Laboratorios Farmaceuticos S.A.

Data source: Ache Laboratorios Farmaceuticos S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.